NCT04262414

Brief Summary

Up to 15 able-bodied individuals will participate in one testing session to evaluate the effectiveness of the A-FES system. Up to 20 individuals with SCI will participate in 12 sessions of A-FES therapy. At each session, participants will stand on a force plate (Accu Sway, AMTI, USA) with the A-FES system (Compex Motion II, Compex Motion, Switzerland) donned. The centre of pressure (COP) will be calculated in real time using the force plate data. The calculated COP will be presented to participants on a monitor and they will be instructed to shift their COP in the indicated directions as represented by a cursor (i.e. training with visual feedback). The intensity of electrical stimulation provided by the A-FES system will be regulated by the measured COP in a closed-loop manner. In this study we propose to develop and evaluate the clinically-feasible A-FES system for the training of standing balance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 10, 2020

Completed
Last Updated

May 23, 2023

Status Verified

February 1, 2020

Enrollment Period

1.5 years

First QC Date

February 4, 2020

Last Update Submit

May 19, 2023

Conditions

Keywords

BalanceFunctional Electrical Stimulation

Outcome Measures

Primary Outcomes (3)

  • Berg Balance Scale

    Assesses static and dynamic standing balance; score 0-56; higher score means a better outcome

    Change from Baseline Berg Balance Scale at 8 weeks

  • Mini-Balance Evaluation Systems Test

    Assesses four balance control systems, including anticipatory balance, reactive postural control, sensory orientation and dynamic gait

    Change from Baseline Mini-Balance Evaluation Systems Test at 8 weeks

  • Activities-specific Balance Confidence Scale

    A measure of balance self-efficacy; mean score of 0-100; higher score means a better outcome (i.e. high balance confidence)

    Change from Baseline Activities-specific Balance Confidence Scale at 8 weeks

Secondary Outcomes (3)

  • Static standing balance

    Through study completion, average of 8 weeks

  • Dynamic standing balance

    Through study completion, average of 8 weeks

  • Semi-structured interview

    up to 8 weeks post-intervention

Interventions

The device used was a prototype closed-loop FES system to improve standing balance by activating the ankle plantar flexors and dorsiflexors (i.e. A-FES system). As a closed-loop system, the body's position and velocity are continually monitored, and the level of stimulation adjusted accordingly on a moment-to-moment basis. This differs from currently available FES units, which do not monitor body movement and therefore, provide a constant level of stimulation unless manually adjusted by the user/PT. The control strategy used in the A-FES system mimics the physiological control system in able-bodied people, meaning it has the potential to "re-educate" normal movement patterns.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A traumatic or non-traumatic, non-progressive (AIS) C or D SCI;
  • ≥18 years old;
  • Able to stand independently for 60s;
  • Moderate level of trunk control as evidenced by the ability to reach forward \>2 inches in standing (i.e. score of 2 on the BBS Reaching Forward task50,51); and
  • Free of any other condition besides SCI that significantly affects walking or balance (e.g., no vestibular disorder, significant vision loss, stroke).

You may not qualify if:

  • Severe spasticity in the legs;
  • Contractures in the lower extremities that prevent achieving a neutral hip and ankle position, or extended knee;
  • A prior lower extremity fragility fracture;
  • An injection of botulinum toxin to leg muscles in the past six months;
  • Peripheral nerve damage in the legs (i.e. leg muscles unresponsive to electrical stimulation);
  • A pressure sore (\>grade 2) on the pelvis or trunk where the safety harness is applied; o
  • Contraindications for FES52 (i.e. implanted electronic device, active cancer or radiation in past 6 months, epilepsy, skin rash/wound at a potential electrode site).
  • Participants will be withdrawn from the study if FES irritates their skin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lyndhurst Centre, Toronto Rehabilitation Institute-UHN

Toronto, Ontario, M4G 3V9, Canada

Location

Related Publications (1)

  • Houston DJ, Unger J, Lee JW, Masani K, Musselman KE. Perspectives of individuals with chronic spinal cord injury following novel balance training involving functional electrical stimulation with visual feedback: a qualitative exploratory study. J Neuroeng Rehabil. 2021 Apr 1;18(1):57. doi: 10.1186/s12984-021-00861-z.

MeSH Terms

Conditions

Spinal Cord InjuriesSpinal Cord Diseases

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Kristin E Musselman, PhD

    University of Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2020

First Posted

February 10, 2020

Study Start

April 30, 2017

Primary Completion

November 14, 2018

Study Completion

June 5, 2019

Last Updated

May 23, 2023

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations